Dietary Phytochemicals as a Potential Source for Targeting Cancer Stem Cells

References

• Sivalingam KS, Paramasivan P, Weng CF, Viswanadha V. Neferine potentiates the antitumor effect of cisplatin in human lung adenocarcinoma cells via a mitochondria-mediated apoptosis pathway. J Cell Biochem. 2017;118(9):2865–2876. doi:10.1002/jcb.25937.
   PubMed Web of Science ®Google Scholar
• Zhou J, Li P, Xue X, He S, Kuang Y, Zhao H, et al. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicol Lett. 2013;222(2):139–145. doi:10.1016/j.toxlet.2013.07.022.
   PubMed Web of Science ®Google Scholar
• Oh J, Hlatky L, Jeong Y-S, Kim D. Therapeutic effectiveness of anticancer phytochemicals on cancer stem cells. Toxins. 2016;8(7):199. doi:10.3390/toxins8070199.
   Web of Science ®Google Scholar
• Kuşoğlu A, Avcı ÇB. Cancer stem cells: a brief review of current status. Gene. 2019;681:80–85.
   PubMed Web of Science ®Google Scholar
• Koury J, Zhong L, Hao J. Targeting signaling pathways in cancer stem cells for cancer treatment. Stem Cells Int. 2017;2017:1–10. doi:10.1155/2017/2925869.
   Web of Science ®Google Scholar
• Yang Y, Li X, Wang T, Guo Q, Xi T, Zheng L. Emerging agents that target signaling pathways in cancer stem cells. J Hematol Oncol. 2020;13(1):1–18. doi:10.1186/s13045-020-00901-6.
   PubMed Web of Science ®Google Scholar
• Matsui WH. Cancer stem cell signaling pathways. Medicine. 2016;95(1 Suppl 1):S8–S19.
   PubMedGoogle Scholar
• Cho Y, Kim YK. Cancer stem cells as a potential target to overcome multidrug resistance. Front Oncol. 2020;10:764. doi:10.3389/fonc.2020.00764.
   PubMed Web of Science ®Google Scholar
• Selvi SK, Vinoth A, Varadharajan T, Weng CF, Padma VV. Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells). Food Chem Toxicol. 2017;103:28–40. doi:10.1016/j.fct.2017.02.020.
   PubMed Web of Science ®Google Scholar
• Scarpa E-S, Ninfali P. Phytochemicals as innovative therapeutic tools against cancer stem cells. Int J Mol Sci. 2015;16(7):15727–15742. doi:10.3390/ijms160715727.
   PubMed Web of Science ®Google Scholar
• Kumar G, Farooqui M, Rao CV. Role of dietary cancer-preventive phytochemicals in pancreatic cancer stem cells. Curr Pharmacol Rep. 2018;4(4):326–335. doi:10.1007/s40495-018-0145-2.
   PubMedGoogle Scholar
• Israel BB, Tilghman SL, Parker-Lemieux K, Payton‑Stewart F. Phytochemicals: current strategies for treating breast cancer. Oncol Lett. 2018;15(5):7471–7478. doi:10.3892/ol.2018.8304.
   PubMed Web of Science ®Google Scholar
• Tanveer S, Fathi E, Guy F. Towards new anticancer strategies by targeting cancer stem cells with phytochemical compounds. Cancer Stem Cells-The Cutting Edge: IntechOpen; 2011.
   Google Scholar
• Asokan SM, Mariappan R, Muthusamy S, Velmurugan BK. Pharmacological benefits of neferine - A comprehensive review. Life Sci. 2018;199:60–70. doi:10.1016/j.lfs.2018.02.032.
   PubMed Web of Science ®Google Scholar
• Hewlings S, Kalman D. Curcumin: a review of its’ effects on human health. Foods. 2017;6(10):92. doi:10.3390/foods6100092.
   PubMed Web of Science ®Google Scholar
• Rayburn ER, Ezell SJ, Zhang R. Anti-inflammatory agents for cancer therapy. Mol Cell Pharmacol. 2009;1(1):29–43. doi:10.4255/mcpharmacol.09.05.
   PubMedGoogle Scholar
• Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer. 2007;7(10):791–799. doi:10.1038/nrc2212.
   PubMed Web of Science ®Google Scholar
• Takebe N, Ivy SP. Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res. 2010;16(12):3106–3112. doi:10.1158/1078-0432.CCR-09-2934.
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal. Clin Cancer Res. 2010;16(12):3113–3120. doi:10.1158/1078-0432.CCR-09-2824.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–111. doi:10.1038/35102167.
   PubMed Web of Science ®Google Scholar
• Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 2009;69(4):1302–1313. doi:10.1158/0008-5472.CAN-08-2741.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730–737. doi:10.1038/nm0797-730.
   PubMed Web of Science ®Google Scholar
• Barabé F, Kennedy JA, Hope KJ, Dick JE. Modeling the initiation and progression of human acute leukemia in mice. Science. 2007;316(5824):600–604. doi:10.1126/science.1139851.
   PubMed Web of Science ®Google Scholar
• Cozzio A, Passegué E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003;17(24):3029–3035. doi:10.1101/gad.1143403.
   PubMed Web of Science ®Google Scholar
• Somervaille TC, Cleary ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell. 2006;10(4):257–268. doi:10.1016/j.ccr.2006.08.020.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. doi:10.1007/s00401-007-0243-4.
   PubMed Web of Science ®Google Scholar
• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492–507. doi:10.1056/NEJMra0708126.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA A Cancer J Clin. 2020;70(3):145–164.
   PubMed Web of Science ®Google Scholar
• Kim B, Jung N, Lee S, Sohng JK, Jung HJ. Apigenin inhibits cancer stem cell-like phenotypes in human glioblastoma cells via suppression of c-Met signaling. Phytother Res. 2016;30(11):1833–1840. doi:10.1002/ptr.5689.
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938–1948. doi:10.1056/NEJMra1001389.
   PubMed Web of Science ®Google Scholar
• Ravi M, Tentu S, Baskar G, Prasad SR, Raghavan S, Jayaprakash P, et al. Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells. BMC Cancer. 2015;15:768. doi:10.1186/s12885-015-1784-x.
   PubMed Web of Science ®Google Scholar
• Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer. Cancer Cell. 2016;29(6):783–803. doi:10.1016/j.ccell.2016.05.005.
   PubMed Web of Science ®Google Scholar
• Park JH, Shin JE, Park HW. The role of hippo pathway in cancer stem cell biology. Mol Cells. 2018;41(2):83–92. doi:10.14348/molcells.2018.2242.
   PubMed Web of Science ®Google Scholar
• Li Y-W, Xu J, Zhu G-Y, Huang Z-J, Lu Y, Li X-Q, et al. Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity. Cell Death Discov. 2018;4:105. doi:10.1038/s41420-018-0124-8.
   PubMed Web of Science ®Google Scholar
• Hassanipour-Azgomi S, Mohammadian-Hafshejani A, Ghoncheh M, Towhidi F, Jamehshorani S, Salehiniya H. Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide. Prostate Int. 2016;4(3):118–124. doi:10.1016/j.prnil.2016.07.001.
   PubMed Web of Science ®Google Scholar
• Erdogan S, Turkekul K, Serttas R, Erdogan Z. The natural flavonoid apigenin sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy. Biomed Pharmacother. 2017;88:210–217. doi:10.1016/j.biopha.2017.01.056.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359(11):1143–1154. doi:10.1056/NEJMra0707975.
   PubMed Web of Science ®Google Scholar
• Eskander A, Goldstein DP, Irish JC. Health services research and regionalization of Care-from policy to practice: the Ontario experience in head and neck cancer. Curr Oncol Rep. 2016;18(3):19. doi:10.1007/s11912-016-0500-6.
   PubMed Web of Science ®Google Scholar
• Ketkaew Y, Osathanon T, Pavasant P, Sooampon S. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line. Arch Oral Biol. 2017;74:69–74. doi:10.1016/j.archoralbio.2016.11.010.
   PubMed Web of Science ®Google Scholar
• Lieben L. Keeping breast cancer in check. Nat Rev Cancer. 2017;17(8):455. doi:10.1038/nrc.2017.55.
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–264. doi:10.1038/nrc3239.
   PubMed Web of Science ®Google Scholar
• Coombs MRP, Harrison ME, Hoskin DW. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells. Cancer Lett. 2016;380(2):424–433. doi:10.1016/j.canlet.2016.06.023.
   PubMed Web of Science ®Google Scholar
• Yano S, Umeda D, Maeda N, Fujimura Y, Yamada K, Tachibana H. Dietary apigenin suppresses IgE and inflammatory cytokines production in C57BL/6N mice. J Agric Food Chem. 2006;54(14):5203–5207. doi:10.1021/jf0607361.
   PubMed Web of Science ®Google Scholar
• Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, et al. Early detection of sporadic pancreatic cancer: summative review. Pancreas. 2015;44(5):693–712. doi:10.1097/MPA.0000000000000368.
   PubMed Web of Science ®Google Scholar
• Adamska A, Domenichini A, Falasca M. Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci. 2017;18(7):1338. doi:10.3390/ijms18071338.
   PubMed Web of Science ®Google Scholar
• Li P, Tian W, Ma X. Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Mol Cancer. 2014;13:138. doi:10.1186/1476-4598-13-138.
   PubMed Web of Science ®Google Scholar
• Xu Q, Ma J, Lei J, Duan W, Sheng L, Chen X, et al. Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Biomed Res Int. 2014;2014:546353. doi:10.1155/2014/546353.
   PubMed Web of Science ®Google Scholar
• Chin Y-W, Jung H-A, Chai H, Keller WJ, Kinghorn AD. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen). Phytochemistry. 2008;69(3):754–758. doi:10.1016/j.phytochem.2007.09.023.
   PubMed Web of Science ®Google Scholar
• Jittiporn K, Suwanpradid J, Patel C, Rojas M, Thirawarapan S, Moongkarndi P, et al. Anti-angiogenic actions of the mangosteen polyphenolic xanthone derivative α-mangostin. Microvasc Res. 2014;93:72–79. doi:10.1016/j.mvr.2014.03.005.
   PubMed Web of Science ®Google Scholar
• Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, et al. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer Lett. 2014;347(1):129–138. doi:10.1016/j.canlet.2014.02.003.
   PubMed Web of Science ®Google Scholar
• Ma Y, Yu W, Shrivastava A, Srivastava RK, Shankar S. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: molecular mechanisms involving Sonic hedgehog and Nanog. J Cell Mol Med. 2019;23(4):2719–2730. doi:10.1111/jcmm.14178.
   PubMed Web of Science ®Google Scholar
• Morgan R, Mortensson E, Williams A. Targeting LGR5 in colorectal cancer: therapeutic gold or too plastic? Br J Cancer. 2018;118(11):1410–1418. doi:10.1038/s41416-018-0118-6.
   PubMed Web of Science ®Google Scholar
• Moore N, Lyle S. Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol. 2011;2011:1–11. doi:10.1155/2011/396076.
   Google Scholar
• Stillwell AP, Buettner PG, Siu SK, Stitz RW, Stevenson AR, Ho Y-H. Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer. Dis Colon Rectum. 2011;54(5):535–544. doi:10.1007/DCR.0b013e3182083d9d.
   PubMed Web of Science ®Google Scholar
• Jo M, Kwon JH, Joo Y-H, Kim S-E, Jung S-A, Seo S-Y, et al. Sa1203-inhibitory effect of cancer stem cells by α-Mangostin in colorectal cancer. Gastroenterology. 2018;154(6):S-276. doi:10.1016/S0016-5085(18)31284-8.
   Web of Science ®Google Scholar
• Zhang K-j, Gu Q-l, Ming YK, Wang X-j, X J. Anticarcinogenic effects of α-mangostin: a review. Planta Med. 2017;83(3-04):188–202. doi:10.1055/s-0042-119651.
   PubMed Web of Science ®Google Scholar
• Rivera E, Gomez H. Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res. 2010;12(Suppl 2):S2.
   PubMedGoogle Scholar
• Milne RL, Osorio A, y Cajal TR, Vega A, Llort G, De La Hoya M, et al. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res. 2008;14(9):2861–2869. doi:10.1158/1078-0432.CCR-07-4436.
   PubMed Web of Science ®Google Scholar
• Somasundaram V, Hemalatha SK, Pal K, Sinha S, Nair AS, Mukhopadhyay D, et al. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells. BMC Cancer. 2016;16:336. doi:10.1186/s12885-016-2372-4.
   PubMed Web of Science ®Google Scholar
• Reshma RS, Sreelatha KH, Somasundaram V, Satheesh Kumar S, Nadhan R, Nair RS, Srinivas P. Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells. Pharmacol Res. 2016;105:134–145. doi:10.1016/j.phrs.2016.01.012.
   PubMed Web of Science ®Google Scholar
• Tolba MF, Omar HA, Azab SS, Khalifa AE, Abdel-Naim AB, Abdel-Rahman SZ. Caffeic acid phenethyl ester: a review of its antioxidant activity, protective effects against ischemia-reperfusion injury and drug adverse reactions. Crit Rev Food Sci Nutr. 2016;56(13):2183–90P38. doi:10.1080/10408398.2013.821967.
   PubMed Web of Science ®Google Scholar
• Kanimozhi G, Prasad N. Anticancer effect of caffeic acid on human cervical cancer cells. Coffee in health and disease prevention. Amsterdam: Elsevier; 2015. pp. 655–661.
   Google Scholar
• Touaibia M, Jean-Francois J, Doiron J. Caffeic Acid, a versatile pharmacophore: an overview. Mini Rev Med Chem. 2011;11(8):695–713. doi:10.2174/138955711796268750.
   PubMed Web of Science ®Google Scholar
• Omene CO, Wu J, Frenkel K. Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells. Invest New Drugs. 2012;30(4):1279–1288. doi:10.1007/s10637-011-9667-8.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang F, Chen L, Yang Y, Cao S, Ye Y, et al. Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo. FEBS Open Bio. 2015;5:466–475. doi:10.1016/j.fob.2015.05.009.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li Y, Wang K, Wang Y, Yin W, Li L. P38/NF-κB/snail pathway is involved in caffeic acid-induced inhibition of cancer stem cells-like properties and migratory capacity in malignant human keratinocyte. PLoS One. 2013;8(3):e58915. doi:10.1371/journal.pone.0058915.
   PubMed Web of Science ®Google Scholar
• El-Khattouti A, Sheehan NT, Monico J, Drummond HA, Haikel Y, Brodell RT, et al. CD133+ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: significance for melanoma treatment. Cancer Lett. 2015;357(1):83–104. doi:10.1016/j.canlet.2014.10.043.
   PubMed Web of Science ®Google Scholar
• Kilani-Jaziri S, Mokdad-Bzeouich I, Krifa M, Nasr N, Ghedira K, Chekir-Ghedira L. Immunomodulatory and cellular anti-oxidant activities of caffeic, ferulic, and p-coumaric phenolic acids: a structure-activity relationship study. Drug Chem Toxicol. 2017;40(4):416–424. doi:10.1080/01480545.2016.1252919.
   PubMed Web of Science ®Google Scholar
• Jahnke MN, Hwang S, Griffith JL, Shwayder T. Cantharidin for treatment of facial molluscum contagiosum: a retrospective review. J Am Acad Dermatol. 2018;78(1):198–200. doi:10.1016/j.jaad.2017.08.044.
   PubMed Web of Science ®Google Scholar
• Whitman DW, Andrés MF, Martínez-Díaz RA, Ibáñez-Escribano A, Olmeda AS, González-Coloma A. Antiparasitic Properties of Cantharidin and the Blister Beetle Berberomeloe majalis (Coleoptera: Meloidae). Toxins. 2019;11:234. doi:10.3390/toxins11040234.
   Web of Science ®Google Scholar
• Moed L, Shwayder TA, Chang MW. Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol. 2001;137(10):1357–1360. doi:10.1001/archderm.137.10.1357.
   PubMedGoogle Scholar
• Pajovic B, Radosavljevic M, Radunovic M, Radojevic N, Bjelogrlic B. Arthropods and their products as aphrodisiacs—review of literature. Eur Rev Med Pharmacol Sci. 2012;16(4):539–547.
   PubMed Web of Science ®Google Scholar
• James PJ, Thorpe N, Thorpe I. Ancient inventions. New York: Random House Digital, Inc.; 1995.
   Google Scholar
• Le A-P, Zhang L-L, Liu W, Shi Y-F. Cantharidin inhibits cell proliferation and induces apoptosis through G2/M phase cell cycle arrest in hepatocellular carcinoma stem cells. Oncol Rep. 2016;35(5):2970–2976. doi:10.3892/or.2016.4684.
   PubMed Web of Science ®Google Scholar
• Wang W-J, Wu M-Y, Shen M, Zhi Q, Liu Z-Y, Gong F-R, et al. Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib. Int J Oncol. 2015;47(5):1912–1922. doi:10.3892/ijo.2015.3156.
   PubMed Web of Science ®Google Scholar
• Hu L, Lu J, Cheng J, Rao Q, Li Z, Hou H, et al. Structural insight into substrate preference for TET-mediated oxidation. Nature. 2015;527(7576):118–122. doi:10.1038/nature15713.
   PubMed Web of Science ®Google Scholar
• Hu L, Li Z, Cheng J, Rao Q, Gong W, Liu M, et al. Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell. 2013;155(7):1545–1555. doi:10.1016/j.cell.2013.11.020.
   PubMed Web of Science ®Google Scholar
• Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466(7310):1129–1133. doi:10.1038/nature09303.
   PubMed Web of Science ®Google Scholar
• Tabasum S, Singh RP. Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition. Chem Biol Interact. 2019;303:14–21. doi:10.1016/j.cbi.2019.02.020.
   PubMed Web of Science ®Google Scholar
• Song B, Guan S, Lu J, Chen Z, Huang G, Li G, et al. Suppressive effects of fisetin on mice T lymphocytes in vitro and in vivo. J Surg Res. 2013;185(1):399–409. doi:10.1016/j.jss.2013.05.093.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang Z, Peng C, You J, Shen J, Han S, et al. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling. Carcinogenesis. 2014;35(11):2544–2554. doi:10.1093/carcin/bgu187.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang Z, Wang Y, Xie X, Shen J, Peng C, et al. Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation. Oncotarget. 2015;6(12):9854–9876. doi:10.18632/oncotarget.3396.
   PubMedGoogle Scholar
• Hu F-W, Yu C-C, Hsieh P-L, Liao Y-W, Lu M-Y, Chu P-M. Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation. Oncotarget. 2017;8(55):93912–93923. doi:10.18632/oncotarget.21338.
   PubMedGoogle Scholar
• Lin Y, Sun H, Dang Y, Li Z. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells. Oncol Rep. 2018;39(2):687–694. doi:10.3892/or.2017.6154.
   PubMed Web of Science ®Google Scholar
• Dandawate PR, Subramaniam D, Jensen RA, Anant S. Targeting cancer stem cells and signaling pathways by phytochemicals: novel approach for breast cancer therapy. Semin Cancer Biol. 2016;40-41:192–208. doi:10.1016/j.semcancer.2016.09.001.
   PubMed Web of Science ®Google Scholar
• Ariga T, Seki T. Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review. Biofactors. 2006;26(2):93–103. doi:10.1002/biof.5520260201.
   PubMed Web of Science ®Google Scholar
• Li X, Meng Y, Xie C, Zhu J, Wang X, Li Y, et al. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway. J Cell Biochem. 2018;119(5):4134–4141. doi:10.1002/jcb.26613.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Kaschula CH, Priedigkeit N, Lee AV, Singh SV. Forkhead box Q1 is a novel target of breast cancer stem cell inhibition by diallyl trisulfide. J Biol Chem. 2016;291(26):13495–13508. doi:10.1074/jbc.M116.715219.
   PubMed Web of Science ®Google Scholar
• Malki A, El-Saadani M, Sultan AS. Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Bio Ther. 2009;8(22):2174–2184. doi:10.4161/cbt.8.22.9882.
   Web of Science ®Google Scholar
• Zhang Q, Li X-T, Chen Y, Chen J-Q, Zhu J-Y, Meng Y, et al. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells. Cancer Chemother Pharmacol. 2018;81(6):969–977. doi:10.1007/s00280-018-3565-0.
   PubMed Web of Science ®Google Scholar
• Jung Y, Park H, Zhao H-Y, Jeon R, Ryu J-H, Kim W-Y. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent. Mol Cells. 2014;37(7):547–553. doi:10.14348/molcells.2014.0158.
   PubMed Web of Science ®Google Scholar
• Lin S-Z, Wei W-T, Chen H, Chen K-J, Tong H-F, Wang Z-H, et al. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. PLoS One. 2012;7(8):e42146. doi:10.1371/journal.pone.0042146.
   PubMed Web of Science ®Google Scholar
• Masaldan S, Iyer VV. Exploration of effects of emodin in selected cancer cell lines: enhanced growth inhibition by ascorbic acid and regulation of LRP1 and AR under hypoxia-like conditions. J Appl Toxicol. 2014;34(1):95–104. doi:10.1002/jat.2838.
   PubMed Web of Science ®Google Scholar
• Huang P-H, Huang C-Y, Chen M-C, Lee Y-T, Yue C-H, Wang H-Y, et al. Emodin and aloe-emodin suppress breast cancer cell proliferation through ERα inhibition. Evid Based Complement Alternat Med. 2013;2013:376123. doi:10.1155/2013/376123.
   PubMed Web of Science ®Google Scholar
• Xue H, Chen Y, Cai X, Zhao L, He A, Guo K, et al. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells. Anti-Cancer Drugs. 2013;24(9):937–944. doi:10.1097/CAD.0b013e328364efe0.
   PubMed Web of Science ®Google Scholar
• Xie M-J, Ma Y-H, Miao L, Wang Y, Wang H-Z, Xing Y-Y, et al. Emodin-provoked oxidative stress induces apoptosis in human colon cancer HCT116 cells through a p53-mitochondrial apoptotic pathway. Asian Pac J Cancer Prev. 2014;15(13):5201–5205. doi:10.7314/apjcp.2014.15.13.5201.
   PubMedGoogle Scholar
• Sun Y, Wang X, Zhou Q, Lu Y, Zhang H, Chen Q, et al. Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo. Oncol Rep. 2015;33(1):338–346. doi:10.3892/or.2014.3585.
   PubMed Web of Science ®Google Scholar
• Zu C, Zhang M, Xue H, Cai X, Zhao L, He A, et al. Emodin induces apoptosis of human breast cancer cells by modulating the expression of apoptosis-related genes. Oncol Lett. 2015;10(5):2919–2924. doi:10.3892/ol.2015.3646.
   PubMed Web of Science ®Google Scholar
• Chen H, Hsieh W, Chang W, Chung J. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol. 2004;42(8):1251–1257. doi:10.1016/j.fct.2004.03.002.
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhou N, Ying P, Zhang T, Liang R, Jiang X. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K/AKT pathways. Open Life Sci. 2019;13(1):489–496. doi:10.1515/biol-2018-0058.
   PubMed Web of Science ®Google Scholar